Latest News about MIRM
Recent news which mentions MIRM
Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session
November 09, 2022
From Benzinga
Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday
October 26, 2022
From Benzinga
Analysts Expect Mirum Pharma's Liver Disease Candidate Might Exceed Rival Product's Penetration
October 25, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2022
September 01, 2022
From Benzinga
'It Is Too Sizzling For Me': Why Jim Cramer Isn't Buying This 'Red Hot' Group Of Stocks
August 30, 2022
From Benzinga
Looking Into Mirum Pharmaceuticals's Return On Capital Employed
August 23, 2022
Tickers
MIRM
From Benzinga
Here's Why Mirum Pharmaceuticals Stock Is Getting Hammered
August 10, 2022
Tickers
MIRM
From Benzinga
From Benzinga
From Benzinga
83 Biggest Movers From Yesterday
May 06, 2022
From Benzinga
57 Stocks Moving In Thursday's Mid-Day Session
May 05, 2022
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
April 07, 2022
From Benzinga
From Benzinga
Earnings Scheduled For March 9, 2022
March 09, 2022
From Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
March 06, 2022
From Benzinga
Earnings Scheduled For November 15, 2021
November 15, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
November 14, 2021
From Benzinga
10 Biggest Price Target Changes For Thursday
September 30, 2021
From Benzinga
FDA Approves First Treatment For Alagille Syndrome-Associated Cholestatic Pruritus From Mirum Pharma
September 29, 2021
Tickers
MIRM
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 29, 2021
From Benzinga
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
From Benzinga
Mirum, Takeda Ink Maralixibat Licensing Pact In Japan
September 21, 2021
From Benzinga
What 5 Analyst Ratings Have To Say About Mirum Pharmaceuticals
September 20, 2021
Tickers
MIRM
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.